Driehaus Capital Management LLC Neuronetics, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $495,000 - $1.15 Million	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $182,000 - $587,000	100,000 New	100,000 $486,000
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $3.47 Million - $6.91 Million	-217,135 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$24.32 - $37.54 $1.14 Million - $1.75 Million	-46,698 Reduced 17.7%	217,135 $6.96 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $7.02 Million - $7.33 Million	263,833 New	263,833 $7.02 Million

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $63.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.